The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When "non-urgent" does not mean "deferrable"

MeSH terms

• Betacoronavirus
• COVID-19
• Coronavirus Infections / therapy
• Gastroenterology / organization & administration*
• Health Care Rationing
• Humans
• Inflammatory Bowel Diseases / therapy*
• Pandemics
• Pneumonia, Viral / therapy
• Quality Assurance, Health Care / standards
• Recurrence
• Risk Assessment
• SARS-CoV-2